GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹49 Cr | ₹91 Cr | ₹64 Cr | ₹39 Cr | ₹40 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹49 Cr |
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹40 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹49 Cr | -46.42 | |
| Mar2025 | ₹91 Cr | 41.76 | |
| Mar2024 | ₹64 Cr | 62.66 | |
| Mar2023 | ₹39 Cr | -2.08 | |
| Mar2022 | ₹40 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,942.4 Cr | 2.3% | 4.9% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 2.3% |
4.9% |
-18.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses